Business Context and Reporting Period
Company: Inmune Bio, Inc. (INMB)
Filing Type: Form 8-K (Current Report)
Date of Report: October 11, 2024
Reporting Period: Event date of October 11, 2024
Business Context: The registrant is an emerging growth company incorporated in Nevada, with principal executive offices in Boca Raton, Florida. The filing announces a corporate event rather than financial results.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes to financial position or operations are reported in this filing. The document solely discloses a scheduled management participation in an external conference.
Guidance, Outlook, and Management Commentary
- Upcoming Event: Management will participate in the Maxim Healthcare Virtual Summit scheduled for October 15-17, 2024.
- Press Release: A press release detailing the event is attached as Exhibit 99.1 and incorporated by reference.
- Guidance/Risks: No new guidance, risk factors, contingencies, or unusual items are disclosed in this specific filing.
Key Facts for Investor Verification
- Verify the date and agenda of the Maxim Healthcare Virtual Summit (October 15-17, 2024).
- Review the attached press release (Exhibit 99.1) for specific details on management's presentation topics.
- Confirm that no financial results or material contracts were announced alongside this event notice.